Conagra Brands reported fiscal 2025 net sales of nearly $12 billion, extending a multi-year track record of low-single-digit revenue growth in its branded portfolio. The company’s refrigerated and frozen segments together accounted for approximately 60% of total net sales, driven by established flagship brands such as Birds Eye®, Healthy Choice® and Marie Callender’s®. While overall volume gains were modest, Conagra’s focus on higher-margin, value-added frozen meals helped mitigate input cost pressure, resulting in an operating margin that management described as "stable to slightly up" compared to the prior year.

Conagra’s recently published Future of Frozen Food 2026 report underscores the $93.5 billion size of the U.S. frozen food aisle and identifies four transformative trends: protein-packed formats generating $12 billion in annual sales and growing at double-digit rates; restaurant-style offerings totaling $14.3 billion; family-style, multi-serve products accounting for roughly $12 billion; and frozen breakfast items expanding beyond morning meals. Data sources from Circana, NielsenIQ Label Insight, Tastewise and Similarweb reveal that high-protein and takeout-style frozen foods are outpacing category growth, particularly among Millennials and Gen Z households.

Conagra’s Demand Science team leverages third-party partnerships and proprietary analytics to accelerate new product development and on-shelf merchandising. In fiscal 2025 the company introduced 18 new frozen SKUs focused on protein-forward nutrition, including plant-based entrées featuring pea protein and edamame, as well as premium, restaurant-inspired dishes under its P.F. Chang’s Home Menu® and Banquet® banners. Conagra also expanded its value-size multi-serve platform, which now represents more than 40% of total frozen aisle sales, to address rising consumer demand for budget-friendly, shareable meals.

As consumer budgets remain under scrutiny, Conagra’s strong presence in the frozen aisle positions it to capture incremental share from fresh and refrigerated categories. Management has guided for low-to-mid single-digit organic net sales growth in fiscal 2026, supported by expanded distribution of new protein-rich SKUs and a planned marketing investment of roughly $150 million. Investors will be watching closely for improvements in gross margin rates, especially as commodity headwinds ease and accelerated innovation drives higher price realization across core frozen platforms.